Anticancer Potential of Diphenyl Carbonate- Crosslinked Cyclodextrin Nanocarrier Loaded with Allyl Methyl Sulfide in a DMBA-Induced Oral Squamous Cell Carcinoma Model

Oral Squamous Cell Carcinoma (OSCC) is the most common malignant tumour and the most resistant to treatment. The lack of a therapy that significantly alters its course necessitates for urgent need to create novel drug delivery formulations. By increasing accessibility and stability, lowering effective dosages and minimising therapeutic adverse effects, nanomedicine can significantly enhance the suppression of cancer cells. This study investigates the chemopreventive effects of Allyl Methyl Sulfide-Loaded Nanosponge (AMS-NS) and Allyl Methyl Sulfide (AMS) on DMBA-induced Hamster Buccal Pouch Carcinogenesis (HBPCs). By topically applying 0.5% DMBA thrice weekly for ten weeks, the left buccal pouches of male golden Syrian hamsters developed oral tumours. In our study, DMBA-treated hamsters showed 100% tumour development, changed levels of antioxidants, detoxifying agents, and Lipid Peroxidation (LPO) products as compared to control hamsters. The results of the current biochemical and histological research show that AMS-NS-treated hamsters have a tumour-reversing effect. Major Findings: This study found that AMS-NS modified metabolic profiles (antioxidants, detoxification, and LPO) and reduced tumour formation in DMBA-induced oral carcinogenesis.

View article page

Download PDF